Today, we feature a specialty pharmaceuticals stock,
Agios Pharmaceuticals Inc (NASDAQ: AGIO) as the top
momentum gainer to watch since it gained over 17% in the last two consecutive
trading days with increased trading volumes. During the last trading session,
AGIO was among the top gainers in the U.S healthcare sector after gaining
over 18.6% and closed at its 52-week high of $42.19 while recording significant
volumes of 1.06 million shares. During the past 5-trading sessions, AGIO
gained over 68.5% with 5-day average volumes of 419,980 shares, while the
stock accumulated over 75% during the past month with daily average volume
of 229,183 shares.
Company Description:
Agios Pharmaceuticals Inc (NASDAQ: AGIO) discovers and develops therapeutics
in the field of cancer metabolism. The company develops drugs focusing
on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals
operates in the United States.
1-Year Stock Chart:
Source: Bloomberg
